Your browser doesn't support javascript.
loading
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.
Harris, Jeffrey M; Cabanski, Christopher R; Scheerens, Heleen; Samineni, Divya; Bradley, Mary S; Cochran, Colette; Staubach, Petra; Metz, Martin; Sussman, Gordon; Maurer, Marcus.
Afiliação
  • Harris JM; Genentech, Inc, South San Francisco, Calif. Electronic address: harris.jeffrey@gene.com.
  • Cabanski CR; Genentech, Inc, South San Francisco, Calif.
  • Scheerens H; Genentech, Inc, South San Francisco, Calif.
  • Samineni D; Genentech, Inc, South San Francisco, Calif.
  • Bradley MS; Genentech, Inc, South San Francisco, Calif.
  • Cochran C; Genentech, Inc, South San Francisco, Calif.
  • Staubach P; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
  • Metz M; Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Sussman G; Division of Clinical Immunology and Allergy, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Maurer M; Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité-Universitätsmedizin Berlin, Berlin, Germany.
J Allergy Clin Immunol ; 138(6): 1730-1732, 2016 12.
Article em En | MEDLINE | ID: mdl-27567329
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Urticária / Antialérgicos / Omalizumab Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Urticária / Antialérgicos / Omalizumab Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article